Medicine OBSERVATIONAL STUDY Association Between Tuberculosis Parkinson Disease A Nationwide PopulationBased Cohort Study ChihHao Shen MD ChungHsing Chou MD FengCheng Liu MD TeYu Lin MD WenYen Huang MD YuChiao Wang MSc ChiaHung Kao MD Abstract Few studies investigated association tuberculosis TB Parkinson disease PD This nationwide popu lationbased retrospective cohort study investigated risk PD patients TB We selected patients newly diagnosed TB International Classiﬁcation Diseases Ninth Revision Clinical Modiﬁcation 011 2000 2009 Taiwan National Health Insurance Database TB cohort The comparison cohort nonTB cohort frequency matched TB cohort ratio 41 sex age index date We analyzed risks PD Cox proportional hazard regression models A total 121951 patients TB 487800 nonTB controls enrolled study The TB cohort 138fold risk PD compared nonTB cohort adjustment age sex comorbidities aHR 95 CI 130146 The adjusted risk PD TB nonTB Editor Carlo Torti Received July 30 2015 revised December 7 2015 accepted January 31 2016 From Division Pulmonary Critical Care Medicine CHS Department Internal Medicine Department Neurology CHC Division RheumatologyImmunology Allergy FCL Division Infectious Diseases Tropical Medicine TYL Department Internal Medicine Department Radiation Oncology WYH TriService General Hospital National Defense Medical Center Taipei School Medicine YCW China Medical University Management Ofﬁce Health Data YCW China Medical University Hospital Graduate Institute Clinical Medical Science CHK College Medicine China Medical University Taichung Department Nuclear Medicine CHK China Medical University Hospital Taichung PET Center Taiwan Correspondence ChiaHung Kao Graduate Institute Clinical Medical Science School Medicine College Medicine China Medical University No 2 YuhDer Road Taichung City 404 Taiwan email d10040mailcmuhorgtw All authors contributed signiﬁcantly authors agreement content manuscript conceptiondesign CHS CHK provision study materials CHK collection andor assembly data authors data analysis interpretation authors manuscript writing authors ﬁnal approval manuscript authors This study supported Taiwan Ministry Health Welfare Clinical Trial Research Center Excellence MOHW105TDUB 212133019 China Medical University Hospital Academia Sinica Taiwan Biobank Stroke Biosignature Project BM10501010037 NRPB Stroke Clinical Trial Consortium MOST 1042325B039 005 Tseng Lien Lin Foundation Taichung Taiwan Taiwan Brain Disease Founda tion Taipei Taiwan Katsuzo Kiyo Aoshima Memorial Funds Japan CMU Aim Top University Plan Ministry Education Taiwan The funders role study design data collection analysis decision publish preparation manu script No additional external funding received study The authors conﬂicts disclose Copyright 2016 Wolters Kluwer Health Inc All rights reserved This open access article distributed Creative Commons AttributionNonCommercialNoDerivatives License 40 permissible download share reproduce work medium provided properly cited The work changed way commercially ISSN 00257974 DOI 101097MD0000000000002883 cohorts increased subgroups regardless age sex comorbidities Combined effect TB comorbidities risk PD signiﬁcant patients TB diabetes aHR 226 95 CI 202252 hypertension aHR 223 95 CI 204244 head injury aHR 232 95 CI 195277 chronic kidney disease aHR 202 95 CI 149 272 chronic obstructive pulmonary disease aHR 184 95 CI 166 205 depression aHR 466 95 CI 359605 dementia aHR 370 95 CI 299459 stroke aHR 256 95 CI 228287 The risk PD higher followup 1 year aHR 178 95 CI 158 200 decreased followup period TB cohort Patients TB independently 138fold risk PD The risk PD decreased followup period TB cohort Physicians aware risk PD patients TB treating patients Medicine 958e2883 Abbreviations CIs conﬁdence intervals HRs hazard ratios ICD9CM International Classiﬁcation Diseases Ninth Revision Clinical Modiﬁcation IRR incidence rate ratio NHI Taiwans National Health Insurance NHIRD National Health Insurance Research Database PD Parkinson disease TB tuberculosis INTRODUCTION T uberculosis TB chronic infection caused Mycobac terium tuberculosis remains crucial public health issues worldwide1 The World Health Organization Global Tuberculosis Report estimated approximately 90 million people developed TB 20131 TB characterized intracellular survival strategies tubercle bacilli2 results chronic pulmonary inflammation release proinflamma tory cytokines3 In addition pulmonary consequences bronchiectasis pleural fibrosis chronic obstructive pul monary disease COPD45 TB associated non pulmonary diseases including malignancy6 ischemic stroke7 acute coronary syndrome8 chronic kidney disease CKD9 depression10 Parkinson disease PD progressively neurodegenerative disorder characterized motor nonmotor manifes tations bradykinesia resting tremor rigidity postural instability autonomic dysfunction neuropsychiatric symptoms sensory sleep difficulties11 The prevalence PD industrialized countries estimated 03 general population approximately 1 people older 60 years12 causes substantially increased economic burden mortality United States Europe1314 Aging genetic susceptibility numerous environmental factors play role onset PD1516 Epidemiologic studies shown diabetes17 hypertension18 head injury19 CKD20 COPD21 depression22 dementia23 stroke24 associated PD Medicine cid2 Volume 95 Number 8 February 2016 wwwmdjournalcom 1 Shen et al Medicine cid2 Volume 95 Number 8 February 2016 Infectious diseases contribute PD development2532 Acute parkinsonian reported subjects infected influenza virus2627 A casecontrol study disclosed PD significantly related infections including mumps scarlet fever influenza whooping cough herpes simplex28 Another nationwide population study shown association central nervous CNS infections higher future risk PD29 Recently positive epidemiological associ ation hepatitis C virus infection PD found30 Moreover studies demonstrated Helicobacter pylori pathogen luminal surface gastric epithelium correlates high PD severity3132 A large TB treatment trial conducted United States Canada shown low mortality rate directly caused TB33 Because TB representative chronic infection2 consider systemic manifestations mortality neurodegenerative diseases concern Taiwan remains TBendemic area In 2008 TB incidence 62 100000 population TB mortality 33 100000 population34 Few studies examined associ ation TB PD Therefore conducted nation wide populationbased cohort study investigate TB increases risk PD METHODS Data Source Thirteen insurance programs reorganized nationwide singlepayer Taiwan National Health Insurance NHI program 1995 NHI program covered 99 23 million Taiwan residents 2000 After Taiwan NHI program established claims data collected com piled large computerized database National Health Insurance Research Database NHIRD The claims data include registry beneficiaries registry catastrophic ill ness registry contracted medical facilities updated year The NHIRD maintained accessible scientific research purposes National Health Research Institutes Taiwan We inpatient files 1 subset NHIRD sample study population These specific subject datasets including inpatient information Taiwan residents 1996 2011 source httpnhirdnhriorgtwenData_Subsetshtml The diseases inpatient files coded according International Classi fication Diseases Ninth Revision Clinical Modification ICD9CM To ensure patient privacy original identification num bers removed NHIRD data release research purposes This study approved Ethics Review Board China Medical University CMUH104REC2115 Study Population This populationbased retrospective cohort study investi gated association risk PD ICD9CM 332 TB ICD9CM 011 Figure 1 shows flowchart patient selection There 200552 patients TB diagnosis database 1996 2011 The TB cohort comprised patients newly diagnosed TB n ¼ 121222 2000 2009 excluded TB patients PD diagnosis date date TB diagnosis n ¼ 3271 missing information sex FIGURE 1 Flowchart presenting study subjects selection 2 wwwmdjournalcom Copyright 2016 Wolters Kluwer Health Inc All rights reserved Medicine cid2 Volume 95 Number 8 February 2016 Tuberculosis Parkinson Disease age n ¼ 0 There 121951 TB patients enrolled TB cohort The index date defined date TB diagnosis For TB case randomly selected 4 persons medical claims TB care frequency matching age 5year span sex individuals nonTB cohort period The index year entry subject eligible study year individual identified included study cohort claims data The exclusion criteria nonTB cohort TB cohort After frequency matching method number nonTB cohort 487800 Patients followed index date PD diagnosis withdrawal NHI program December 31 2011 We considered confounding factors demo graphic factors history coexisting conditions diabetes ICD9CM 250 hypertension ICD9CM 401 405 head injury ICD9CM 3102 800 801 803 804 850 851 853 854 CKD ICD9CM 585 COPD ICD9 CM 490492 494 496 depression ICD9CM 2962 2963 29682 3004 311 dementia ICD9CM 290 2941 3310 stroke ICD9CM 430438 Conditions diagnosed index date considered comorbidities Statistical Analyses The SAS 94 software SAS Institute Cary NC data management statistical analyses The Student t test analyze difference continuous variable age cohorts results presented mean standard deviation SD The x2 test analyze difference categorical variables including sex age group comorbidity history TB nonTB cohorts The cumulative incidences PD calculated study cohorts following formula dividing number PD events sum followup years 1000 personyr The cumulative incidence curves PD created KaplanMeier method tested differences log rank test Poisson regression analysis estimate incidence rate ratio IRR PD TB nonTB cohorts To control confounding risk factors adjusted hazard ratios aHRs 95 confidence intervals 95 CIs estimated multivariable Cox proportional hazard models crude hazard ratios crude HRs PD achieved statistically significant effect particu larly risk factor P values 005 indicated significance 2sided tests RESULTS Table 1 shows comparison demographics comor bidities TB nonTB cohorts The cohorts similar mean age 63 y SD 194 similar sex ratios men 719 frequency matching The TB cohort higher prevalence comorbidities nonTB cohort Table 2 shows risk PD different risk factor These risk factors selected adjustment presented statistically significant effect PD including sex age groups age 65year old age cid365year old TB diabetes hypertension head injury CKD COPD depression dementia stroke crude HR P value 0001 After adjusted multivariable Cox proportional hazard models aHR PD higher 125fold women men The risk PD got increased age aHR ¼ 111 95 CI 102121 cid365year old The risk PD great subject particularly comorbidity example diabetes patient 115fold risk PD nondiabetes patient 95 CI 108123 By end followup period cumulative incidence PD higher TB cohort nonTB cohort log rank test P value 00001 Figure 2 TABLE 1 Comparison Demographics Comorbidity Between TB NonTB Tuberculosis TB No N ¼ 487800 Yes N ¼ 121951 Sex Women Men Age y 65 cid365 Mean SDcid4 Comorbidity Diabetes Hypertension Head injury CKD COPD Depression Dementia Stroke n 137272 350528 207896 279904 636 194 39545 81672 17776 5573 29100 3129 4532 38226 281 719 426 574 811 167 364 114 597 064 093 784 n 34318 87633 51974 69977 637 194 22044 31643 8507 4311 23699 1964 3162 17435 281 719 426 574 181 259 698 354 194 161 259 143 P 099 099 002 00001 00001 00001 00001 00001 00001 00001 00001 CKD ¼ chronic kidney disease COPD ¼ chronic obstructive pulmonary disease SD ¼ standard deviation x2 test cid4 Student t test Copyright 2016 Wolters Kluwer Health Inc All rights reserved wwwmdjournalcom 3 Shen et al Medicine cid2 Volume 95 Number 8 February 2016 TABLE 2 Adjusted Hazard Ratio Parkinson Disease Different Risk Factors Variables Event Crude HR 95 CI Tuberculosis TB No Yes Sex Women Men Age groups y 65 cid365 Comorbidity types Diabetes No Yes Hypertension No Yes Head injury No Yes CKD No Yes COPD No Yes Depression No Yes Dementia No Yes Stroke No Yes 6961 1396 1931 6426 610 7747 7179 1178 5810 2547 7916 441 8188 169 7315 1042 8173 184 8069 288 6944 1413 100 119 113126y 100 136 129143y 100 128 117139y 100 216 203230y 100 291 277305y 100 152 138167y 100 253 217295y 100 258 241275y 100 402 347465y 100 671 596755y 100 331 313351y aHR ¼ adjusted hazard ratio cid4 Multiple analysis including age groups age 65year old age cid365year old sex comorbidities y P 0001 aHR 95 CIcid4 100 127 120135y 100 125 119131y 100 111 102121y 100 115 108123y 100 134 127142y 100 115 104127y 100 131 112153y 100 114 106122y 100 202 173235y 100 242 213274y 100 149 139159y Table 3 illustrates incidence rate PD higher TB cohort 283 1000 personyr nonTB cohort 238 1000 personyr IRR PD 119 fold 95 CI 117122 higher TB cohort nonTB cohort After adjustment age sex comor bidities patients TB 138fold increased risk PD compared people TB aHR 138 95 CI 130146 Sexstratified analysis showed risk PD higher men TB men TB aHR 134 95 CI 125144 higher women TB women TB aHR 148 95 CI 131166 The age specific incidence PD increased age cohorts highest incidence patients TB aged older 65 years 576 1000 personyr Agestratified analysis showed higher risk PD patients TB people TB ages 65 years aHR 169 95 CI 140203 cid365 years aHR 122 95 CI 114130 Compared patients nonTB cohort comorbidity risk PD higher TB cohort comorbidity aHR 133 95 CI 121147 Patients TB cohort comorbidity 132fold higher risk PD 95 CI 122 142 nonTB cohort comorbidity compared Table 4 shows combined effect TB comorbid ities risk PD relation reference group TB comorbidities Most comorbidities TB diag nosis presented higher risk PD diabetes aHR 147 95 CI 137158 hypertension aHR 155 95 CI 147163 CKD aHR 176 95 CI 148210 depression aHR 289 95 CI 243345 dementia aHR 278 95 CI 241320 stroke aHR 184 95 CI 172196 We observed greatest risk PD occurrence reference group TB coexistent comorbidity TB diabetes aHR 226 95 CI 202252 hypertension aHR 223 95 CI 204244 head injury aHR 232 95 CI 195277 CKD aHR 202 95 CI 149272 COPD aHR 184 95 CI 166205 depression aHR 466 95 CI 359605 dementia aHR 370 95 CI 299459 stroke aHR 256 95 CI 228 287 respectively 4 wwwmdjournalcom Copyright 2016 Wolters Kluwer Health Inc All rights reserved Medicine cid2 Volume 95 Number 8 February 2016 Tuberculosis Parkinson Disease model showed patients TB 138fold higher risk PD compared general population We observed patients TB significantly higher PD incidence TB regardless sex age comorbidities Table 3 These findings strength ened observation TB influences PD independently The role infection PD far confirmed The pathogenesis PD associated loss dopaminergic neurons substantia nigra pars compacta wide spread presence asynuclein aggregates15 Viruses influenza virus particular enter substantia nigra cause cell death directly2627 In addition viral infections initiate cytokine storm brain sequelae including activation microglia apoptosis neurons3035 The brain protected bloodbrain barrier CNS infections likely neurological consequences peripheral infections29 However increasing evidence indicates neuroinflammation caused nonCNS infections3638 The association H pylori PD highlights gastrointestinal tract represents vulner able area pathogens induce CNS neuroin flammation313239 TB common chronic infection lung known induce proinflammatory responses3 play key role pathogenesis PD In addition neuroinflammation mechanisms explain observation The parkin protein ubiquitin ligase innate defense mechanism plays key invading M role ubiquitinmediated autophagy tuberculosis40 PARK2 mutations humans wellknown risk factors PD polymorphisms regulatory region PARK2 result reduced expression parkin protein41 Therefore mutations PARK2 imply impaired innate defense mechanism M tuberculosis lead increased susceptibility PD We observed risk PD decreased follow period TB cohort Table 5 A similar correlation infections PD previous studies Two possible explanations proposed obser vation First national guidelines TB diagnosis FIGURE 2 The cumulative incidence Parkinson disease higher TB cohort nonTB cohort log rank test P value 00001 Table 5 presents risk PD patients TB stratified followup period The aHR calculated according followup period index date date PD diagnosis We observed aHR 178fold 95 CI 158200 higher TB cohort nonTB cohort followup period 1 year Compared nonTB cohort aHR PD 135 95 CI 124147 TB cohort followup duration 1 5 years The aHR PD decreased followup period TB cohort DISCUSSION This nationwide populationbased cohort study investigate association TB PD After adjust ment sex age comorbidities Cox proportional hazard TABLE 3 Incidence Adjusted Hazard Ratio Parkinson Disease Stratiﬁed Sex Age Comorbidity YesNo Between With TB NonTB Cohorts Tuberculosis TB Variables Event Rate Event Rate IRR 95 CI aHRcid4 95 CI No Yes Compared With NonTB Cohort Overall Sex Women Men Age yr 65 cid365 Comorbidity No Yes 6961 1564 5397 426 6535 3961 3000 238 187 259 030 433 170 502 1396 367 1029 184 1212 495 901 283 242 302 065 576 157 509 119 117122y 138 130146y 130 125135y 117 114120y 216 210223y 133 130137y 092 089095y 101 098105 148 131166y 134 125144y 169 140203y 122 114130y 133 121147y 132 122142y aHR ¼ adjusted hazard ratio IRR ¼ incidence rate ratio rate ¼ incidence rate 1000 personyr cid4 Multiple analysis including age sex comorbidities y P 0001 Copyright 2016 Wolters Kluwer Health Inc All rights reserved wwwmdjournalcom 5 Shen et al Medicine cid2 Volume 95 Number 8 February 2016 TABLE 4 Adjusted Hazard Ratios Parkinson Disease Associated TB Interaction With Comorbidity Variable Tuberculosis TB No No Yes Yes Tuberculosis TB No No Yes Yes Tuberculosis TB No No Yes Yes Tuberculosis TB No No Yes Yes Tuberculosis TB No No Yes Yes Tuberculosis TB No No Yes Yes Tuberculosis TB No No Yes Yes Tuberculosis TB No No Yes Yes N Event aHRcid4 95 CI Diabetes No Yes No Yes Hypertension No Yes No Yes Head injury No Yes No Yes CKD No Yes No Yes COPD No Yes No Yes Depression No Yes No Yes Dementia No Yes No Yes Stroke No Yes No Yes 448255 39545 99907 22044 406128 81672 90308 31643 470024 17776 113444 8507 482227 5573 117640 4311 458700 29100 98252 23699 484671 3129 119987 1964 483268 4532 118789 3162 449574 38226 104516 17435 6106 855 1073 323 4937 2024 873 523 6646 315 1270 126 6835 126 1353 43 6297 664 1018 378 6834 127 1339 57 6758 203 1311 85 5857 1104 1087 309 100 147 137158z 144 135154z 226 202252z 100 155 147163z 146 136157z 223 204244z 100 125 112140z 147 139157z 232 195277z 100 176 148210z 151 143160z 202 149272z 100 123 113133z 145 135155z 184 166205z 100 289 243345z 149 140158z 466 359605z 100 278 241320z 148 140157z 370 299459z 100 184 172196z 147 138157z 256 228287z aHR ¼ adjusted hazard ratio cid4 Model adjusted age sex y P value interaction z P 0001 P Valuey 03833 08072 00357 01208 06092 06199 04253 04379 treatment developed Taiwan Centers Disease Control CDC past decade42 Taiwan implemented World Health Organization recommended strategy Directly Observed Treatment Short Course program42 Under policies treatment success rate new smearpositive cases reported 2009 12 months followup 8734 The reduction risk PD followup period study indicate successful treatment TB cures TB sub sequently reduces risk PD Second firstline medications TB include rifampicin isoniazid pyrazinamide ethambutol43 Among medi cations rifampicin cytoprotective role variety experimental nonTB conditions44 It suppresses formation asynuclein aggregates alleviates mitochondrial oxidative stress reduces microglial activation improving neuron survival inflammatory conditions44 Although additional research required rifampicin treat M tuberculosis prevent development PD subjects active TB This study limitations First NHIRD lacks information patient behaviors crucial PD risk factors smoking obesity BMI alcoholism exercise occu pation dietary habits Second relevant clinical variables laboratory data imaging results culture reports unavailable study 6 wwwmdjournalcom Copyright 2016 Wolters Kluwer Health Inc All rights reserved Medicine cid2 Volume 95 Number 8 February 2016 Tuberculosis Parkinson Disease TABLE 5 Incidence Adjusted Hazard Ratio Parkinson Disease FollowUp Year Between TB NonTB Cohorts Tuberculosis TB No Yes Compared With NonTB Cohort Variables Event Rate Event Rate IRR 95 CI Follow time 1 15 cid35 1052 3618 2291 220 233 256 399 711 286 404 271 217 184 180187y 116 113119y 085 082088y aHRcid4 95 CI 178 158200y 135 124147y 112 099127 aHR ¼ adjusted hazard ratio IRR ¼ incidence rate ratio rate ¼ incidence rate 1000 personyr cid4 Multiple analysis including age sex comorbidities y P 0001 assess severity TB chronic inflammation patients Third diagnosis PD based clinical presentation neuroimaging findings available NHIRD Finally evidence obtained retrospective cohort study generally lower statistical quality obtained randomized trials potential biases related adjustment confounding variables Bias resulting unknown confounders affected results despite meticulous study design control confound ing factors In conclusion study demonstrated patients TB exhibited 138fold higher risk PD compared general population nationwide populationbased database containing high number TB cases The risk PD decreased followup period TB cohort Phys icians aware risk PD patients TB provide adequate treatment patients prevent PD development REFERENCES 1 World Health Organization Global Tuberculosis Report World Health Organization 2014 2 Dorhoi A Kaufmann SH Perspectives host adaptation response Mycobacterium tuberculosis modulation inflamma tion Semin Immunol 201426533542 3 Kaufmann SH Dorhoi A Inflammation tuberculosis interactions imbalances interventions Curr Opin Immunol 201325441449 4 Allwood BW Myer L Bateman ED A systematic review association pulmonary tuberculosis development chronic airflow obstruction adults Respiration 2013867685 5 Maguire GP Anstey NM Ardian M et al Pulmonary tuberculosis impaired lung function disability quality life highburden setting Int J Tuberc Lung Dis 20091315001506 6 Kuo SC Hu YW Liu CJ et al Association tuberculosis infections nonpulmonary malignancies nationwide popula tionbased study Br J Cancer 2013109229234 7 Sheu JJ Chiou HY Kang JH et al Tuberculosis risk ischemic stroke 3year followup study Stroke 201041244249 8 Chung WS Lin CL Hung CT et al Tuberculosis increases subsequent risk acute coronary syndrome nationwide popula tionbased cohort study Int J Tuberc Lung Dis 2014187983 9 Shen TC Huang KY Chao CH et al The risk chronic kidney disease tuberculosis populationbased cohort study QJM 2015108397403 10 Shen TC Wang CY Lin CL et al People tuberculosis associated subsequent risk depression Eur J Intern Med 201425936940 11 Jankovic J Parkinsons disease clinical features diagnosis J Neurol Neurosurg Psychiatry 200879368376 12 Lau LM Breteler MM Epidemiology Parkinsons disease Lancet Neurol 20065525535 13 Kowal SL Dall TM Chakrabarti R et al The current projected economic burden Parkinsons disease United States Mov Disord 201328311318 14 Mackenbach JP Karanikolos M Looman CW The rise mortality mental neurological diseases Europe 19792009 observational study BMC Public Health 201414840 15 Tolosa E Wenning G Poewe W The diagnosis Parkinsons disease Lancet Neurol 200657586 16 Dexter DT Jenner P Parkinson disease pathology molecular disease mechanisms Free Radic Biol Med 201362132 144 17 Bohnen NI Kotagal V Muller ML et al Diabetes mellitus independently associated severe cognitive impairment Parkinson disease Parkinsonism Relat Disord 20142013941398 18 Qiu C Hu G Kivipelto M et al Association blood pressure hypertension risk Parkinson disease National FINRISK Study Hypertension 20115710941100 19 Gardner RC Burke JF Nettiksimmons J et al Traumatic brain injury later life increases risk Parkinson disease Ann Neurol 201577987995 20 Wang IK Lin CL Wu YY et al Increased risk Parkinsons disease patients endstage renal disease retrospective cohort study Neuroepidemiology 201442204210 21 Li CH Chen WC Liao WC et al The association chronic obstructive pulmonary disease Parkinsons disease nationwide populationbased retrospective cohort study QJM 20151083945 22 Gustafsson H Nordstrom A Nordstrom P Depression subse quent risk Parkinson disease nationwide cohort study Neurology 20158424222429 23 Feldman AL Wirdefeldt K Johansson AL et al Evidence modest familial coaggregation dementia parkinsonism Eur J Epidemiol 2014294956 24 Jellinger KA Prevalence cerebrovascular lesions Parkinsons disease A postmortem study Acta Neuropathol 2003105415419 25 Harris MA Tsui JK Marion SA et al Association Parkinsons disease infections occupational exposure possible vectors Mov Disord 20122711111117 Copyright 2016 Wolters Kluwer Health Inc All rights reserved wwwmdjournalcom 7 Shen et al Medicine cid2 Volume 95 Number 8 February 2016 26 Maurizi CP Was neurovirulent influenza virus cause amyotrophic lateral sclerosis parkinsonismdementia Guam Med Hypotheses 198723325326 36 Collins LM Toulouse A Connor TJ et al Contributions central systemic inflammation pathophysiology Parkinsons disease Neuropharmacology 20126221542168 27 Takahashi M Yamada T Nakajima S et al The substantia nigra 37 Deleidi M Gasser T The role inflammation sporadic major target neurovirulent influenza A virus J Exp Med 199518121612169 familial Parkinsons disease Cell Mol Life Sci 2013704259 4273 28 Vlajinac H Dzoljic E Maksimovic J et al Infections risk factor Parkinsons disease casecontrol study Int J Neurosci 2013123329332 38 McGeer PL McGeer EG Inflammation neurodegeneration Parkinsons disease Parkinsonism Relat Disord 200410suppl 1S37 29 Fang F Wirdefeldt K Jacks A et al CNS infections sepsis risk Parkinsons disease Int J Epidemiol 20124110421049 30 Wu WY Kang KH Chen SL et al Hepatitis C virus infection 39 Deretzi G Kountouras J Polyzos SA et al Gastrointestinal immune brain dialogue implicated neuroinflammatory neurodegenerative diseases Curr Mol Med 201111696707 risk factor Parkinsons disease J Viral Hepat 201522784791 40 Manzanillo PS Ayres JS Watson RO et al The ubiquitin ligase 31 Tan AH Mahadeva S Marras C et al Helicobacter pylori infection associated worse severity Parkinsons disease Parkinson ism Relat Disord 201521221225 32 Kountouras J Zavos C Polyzos SA et al Helicobacter pylori infection Parkinsons disease apoptosis underlying common contributor Eur J Neurol 201219e56 33 Sterling TR Zhao Z Khan A et al Mortality large tuberculosis treatment trial modifiable nonmodifiable risk factors Int J Tuberc Lung Dis 200610542549 34 Lo HY Chou P Yang SL et al Trends tuberculosis Taiwan parkin mediates resistance intracellular pathogens Nature 2013501512516 41 Chopra R Ali S Srivastava AKR et al Mapping PARK2 PACRG overlapping regulatory region reveals LD structure functional variants association leprosy unrelated Indian population groups PLoS Genet 20139e1003578 42 Chiou SJ Huang YT Lee JJ et al Historical research tuberculosis control strategies implications mortality trends Taiwan Int J Tuberc Lung Dis 20111510331037 43 Lawn SD Zumla AI Tuberculosis Lancet 20113785772 20022008 J Formos Med Assoc 2011110501510 44 Bi W Zhu L Jing X et al Rifampicin Parkinsons disease 35 Jang H Boltz DA Webster RG et al Viral parkinsonism Biochim Neurol Sci 201334137141 Biophys Acta 20091792714721 8 wwwmdjournalcom Copyright 2016 Wolters Kluwer Health Inc All rights reserved